Healthcare services
Clinics, hospitals, and care delivery networks with strong clinical outcomes and efficient patient throughput.
Investing in the services, science, and technology that improve lives.
Ageing populations and a widening care gap make healthcare one of the most durable demand curves there is — we invest in businesses that make care better and more accessible, not just more expensive.
Our focus spans medical services, devices, and life sciences with genuine clinical value and defensible positions. Demand here is structural and largely recession-proof; we back businesses solving real bottlenecks in delivery, diagnostics, and treatment, and hold them through the long timelines healthcare rewards.
We back healthcare businesses across services, devices, and life sciences — sectors defined by durable demand and lasting impact.
Our focus is on quality care, clinical innovation, and platforms that make healthcare more accessible and efficient.
We invest across the care continuum — providers, devices, and the platforms connecting them — prioritising businesses that improve outcomes while remaining financially sustainable at scale.
Clinics, hospitals, and care delivery networks with strong clinical outcomes and efficient patient throughput.
Diagnostics, devices, and equipment that improve clinical accuracy or reduce the cost of care delivery.
Pharmaceutical, biotech, and research organisations developing treatments with clear clinical and commercial pathways.
Digital health and care-coordination platforms that make healthcare more accessible without compromising quality.
We build relationships with clinical operators and healthcare entrepreneurs, often years before an investment is formalised.
We review clinical outcomes, regulatory standing, and reimbursement dynamics alongside standard financial due diligence.
We commit capital to expand capacity or accelerate development, matched to the clinical and regulatory timeline involved.
We support governance and growth planning while deferring clinical and operational decisions to experienced practitioners.
We back geographic expansion and new service lines once a care model proves safe, effective, and scalable.
Across the full care continuum — clinics and hospitals, medical devices and diagnostics, pharmaceutical and biotech research, and digital health platforms that coordinate care.
We support governance and growth planning, but clinical and operational decisions are left to experienced practitioners — our role is capital and structure, not clinical judgment.
Strong clinical outcomes, sound regulatory standing, and a clear reimbursement or commercial pathway, reviewed alongside standard financial due diligence.
For investment, partnership, and corporate enquiries.
info@coaxishub.com